AI assistant
REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2017
Jun 16, 2017
29977_dirs_2017-06-16_1dff6125-64c8-4a5b-98a2-5da5a2cea210.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2017-06-14
Reporting Person: STAHL NEIL (EVP Research and Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-14 | Common Stock | M | 20295 | $21.25 | Acquired | 44245 | Direct |
| 2017-06-14 | Common Stock | F | 906 | $475.56 | Disposed | 43339 | Direct |
| 2017-06-14 | Common Stock | F | 10822 | $475.56 | Disposed | 32517 | Direct |
| 2017-06-15 | Common Stock | S | 500 | $462.72 | Disposed | 32017 | Direct |
| 2017-06-15 | Common Stock | S | 100 | $463.91 | Disposed | 31917 | Direct |
| 2017-06-15 | Common Stock | S | 400 | $464.69 | Disposed | 31517 | Direct |
| 2017-06-15 | Common Stock | S | 1244 | $465.49 | Disposed | 30273 | Direct |
| 2017-06-15 | Common Stock | S | 185 | $466.52 | Disposed | 30088 | Direct |
| 2017-06-15 | Common Stock | S | 300 | $467.82 | Disposed | 29788 | Direct |
| 2017-06-15 | Common Stock | S | 900 | $468.63 | Disposed | 28888 | Direct |
| 2017-06-15 | Common Stock | S | 2212 | $469.53 | Disposed | 26676 | Direct |
| 2017-06-15 | Common Stock | S | 2426 | $470.57 | Disposed | 24250 | Direct |
| 2017-06-15 | Common Stock | S | 100 | $471.15 | Disposed | 24150 | Direct |
| 2017-06-15 | Common Stock | S | 100 | $472.95 | Disposed | 24050 | Direct |
| 2017-06-15 | Common Stock | S | 100 | $474.48 | Disposed | 23950 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-14 | Non-Qualified Stock Option (right to buy) | $21.25 | M | 20295 | Disposed | 2019-12-18 | Common Stock (20295) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10000 | Indirect |
| Common Stock | 5000 | Indirect |
| Common Stock | 5647 | Indirect |
Footnotes
F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2: Represents volume-weighted average price of sales of 500 shares of Company stock on June 15, 2017 at prices ranging from $462.38 to $462.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
F3: Represents volume-weighted average price of sales of 400 shares of Company stock on June 15, 2017 at prices ranging from $464.46 to $464.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
F4: Represents volume-weighted average price of sales of 1,244 shares of Company stock on June 15, 2017 at prices ranging from $465.00 to $465.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
F5: Represents volume-weighted average price of sales of 185 shares of Company stock on June 15, 2017 at prices ranging from $466.49 to $466.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
F6: Represents volume-weighted average price of sales of 300 shares of Company stock on June 15, 2017 at prices ranging from $467.70 to $467.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
F7: Represents volume-weighted average price of sales of 900 shares of Company stock on June 15, 2017 at prices ranging from $468.00 to $468.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
F8: Represents volume-weighted average price of sales of 2,212 shares of Company stock on June 15, 2017 at prices ranging from $469.07 to $469.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
F9: Represents volume-weighted average price of sales of 2,426 shares of Company stock on June 15, 2017 at prices ranging from $470.03 to $470.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 15, 2017 at each separate price.
F10: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.